Texas could receive as much as $1.5 billion under a multistate settlement over the national opioid epidemic, Texas Attorney General Ken Paxton has announced.
The roadblocks for prescribing pain medicine are still there. Even after the state introduced a safeguard to help physicians spot illicit prescription use and doctor-shopping, barriers remain.
Beginning Sept. 1, Texas Medicaid will implement updated clinical prior authorization criteria for opioid prescriptions for certain Medicaid fee-for-service and managed care patients.
September 2019 brought what could become a major victory for the state’s handling of opioid addiction. Drugmaker Purdue Pharma – which faced thousands of lawsuits from cities and states, including Texas, for its role in the national opioid crisis – announced it had agreed to a settlement with 24 state attorneys general and other plaintiffs.
The Texas Medical Board is trying to head off confusion about the state’s new 10-day opioid prescribing limit for acute pain, which takes effect on Sunday. TMB’s statement, released Friday, appears to address concerns that the new law means acute pain patients must be completely cut off from opioids beyond the 10-day mark. That’s not the case, according to the statement.
When it came to opioids and pharmacy matters, some of the major pieces of medicine’s 2019 agenda came down to something everyone wishes they had more of: time.
Substance use disorders (SUD) are serious, chronic medical conditions that are manageable with the proper medical treatment and social support.
In an effort to address the very real and debilitating crisis caused by the misuse of pain medicines, the Texas Legislature has passed legislation to mandate that all prescribers and pharmacists check the state's Prescription Drug Monitoring Program (PDMP) before prescribing or dispensing certain medications.
NOTE: The mandate is effective Sept. 1, 2019, for prescribers and pharmacists. It applies to opioids, benzodiazepines, barbiturates, and carisoprodol (Soma), not to all controlled substances.
To help physicians set up accounts and use the new PDMP website Allison Benz, executive director of the Texas Pharmacy Board. demonstrates the new site in this brief, informative TMA-produced video. This five-minute video shows physicians how to set up, use and navigate the site.
Recent questions about Opioids issues:
What happened to the Texas Controlled Substances Registration (CSR) program?
Ask your question now
Chronic pain is one of the most frequent reasons people seek medical attention in the U.S., according to the CDC. If you prescribe opioids for chronic pain, there are things you need to know to protect your patients.
TMA’s new e-book, Monitoring Opioid Therapy for Chronic Pain, serves as a brief resource for that information and more.
Learn More Here
The U.S. Department of Health and Human Services published a Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. The guide covers important issues to consider when changing a patient’s chronic pain therapy, including issues to consider prior to making a change, when initiating a change, and as a patient’s dosage is being tapered.
Read the Complete Guide Here
Read More TMA Opioid Articles
Links below provide timely information from fellow health care leaders in addressing the opioid epidemic:
American Academy of Family Physicians (AAFP) Chronic Pain Resources
AAFP Pain Management and Opioid Abuse
American Academy of Orthopedic Surgeons (AAOS)
American Society of Clinical Oncology (ASCO)
American Society of Interventional Pain Physicians (ASIPP)
American Society of Anesthesiologists
American College of Emergency Physicians
American College of Surgeons
A new, free mobile app provides immediate access to information about medication-assisted treatment (MAT) for opioid use disorder.